In addition to the products that are sold under Somalabs™ own label, all of which are also available as private labels, Somalabs offers a range of private label products, including our multi-facetted approach to managing energy metabolism, our S2023 product, which combines in one tablet all the herbs and botanicals which are known to have beneficial effects in assisting weight loss:

BITTER ORANGE extract for its thermogenic and fat-burning potential; GUARANA and GREEN TEA as sources of caffeine to potentiate the action of the Bitter Orange (with the added advantage of the natural antioxidants in the Green Tea); BEAN ALPHA-AMYLASE INHIBITOR to reduce the enzymatic digestion of starch in the small intestine; ST. JOHN'S WORT for its action on inducing satiety and improving mood; NUTMEG for its potential as a hunger suppressant (from the speculated conversion of myristicin to amphetamines in the brain); GYMNEMA SYLVESTRE for its effects on taste perception and blood sugar levels.

Structure-function statement for S2023:

Bitter Orange (Citrus aurantium) contains small amounts of alkaloids such as synephrine and octopamine, which are direct- and indirect-acting adrenergic agents. Adrenergic agents with beta-agonist activity stimulate lipolysis and increase the resting metabolic rate in some persons, thus increasing the removal and oxidation of fat from adipose tissue stores. This action is potentiated by methylxanthines, such as caffeine, present in Guarana and Green Tea (Camellia sinensis). St. John's Wort (Hypericum perforatum) contains the substance hypericin, which has been shown modify serotonin levels in the brain with consequent effects on mood and satiety. The Great Northern White Bean (Phaseolus vulgaris) contains an inhibitor of the alpha-amylase enzyme that promotes breakdown of starch in the human digestive tract. Ingestion of this inhibitor ("starch-blocker"), which is present in the protein fraction of the bean, can reduce the digestion of starch in foods so that less sugars are absorbed, thus reducing available caloric content of some foods. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Other private label products can be formulated to meet the requirements of customers, with the proviso that such custom formulations will be based on the proper application of pharmacognostical principles. For example, we have formulated a range of "digestion denial" products based on alpha-amylase inhibitors but containing other botanicals that inhibit or modulate the digestion and absorption of carbohydrates other than starch, or affect the metabolic fate of carbohydrate digestion products.

In addition to its own products, Somalabs is also licensed to sell Bari-EFA®, the best and most effective essential fatty acid supplement in the world. This product is available only as a private label, in either standard or enteric-coated format. The enteric-coated version has become extremely popular. The advantage, of course, is that the capsules do not dissolve in the stomach, but in the small intestine, so the residual 'repeating' of fishy tastes that some find objectionable is eliminated. See 'Scientific Background' for details of the science underlying this marvellous product, that has done more to eliminate the signs of essential fatty acid deficiency in those on low-calorie diets than any other product currently available.

Ensuring optimal essential fatty acid status is perhaps one of the most important actions for those on weight loss regimes; it also optimizes thermogenesis and the response to the diet. But providing the omega-6 and omega-3 essential fatty acids in the correct form, the right amounts and the optimal proportions is a prerequisite that must be met if the product is to significantly improve results.

Bari-EFA® is a registered trademark of Bariatrix Nutrition Inc., Lachine, Quebec, Canada.